Meetings on the horizon
Open meetings will be held to obtain public comment on a new proposed LCD or on the revised portion of an existing LCD. The clinical evidence considered in the development and/or revision is included in the Bibliography.
* Open meeting dates, locations, times, and topics are subject to change.
Tentative 2024 JH/JL open meeting schedule*:
Date* |
Time* |
Friday, October 25 |
10:00 a.m. ET |
Current meeting:
Open meeting registration is now available for the JH/JL open meeting below. Our open meeting will be held via webinar only.
Date * |
Attendees |
Location * |
Time * |
Agenda |
Registration |
Friday, September 13 |
Stakeholders and other interested parties |
Webinar only |
10:00 a.m. ET |
Open meeting agenda Proposed LCD DL38712 Transurethral Waterjet Ablation of the Prostate |
Presenters register here Observers register here |
The proposed Jurisdiction L (JL) LCDs are posted on our website.
Open meetings are to allow interested parties the opportunity to make presentations of information and offer comments related to new proposed LCDs and/or the revised portion of a proposed LCD that are in the 45-day open comment period.
Want to get involved? Submit written comments on a proposed LCD or register as a presenter to share your comments during our meeting.
Please read our Open Meeting Fact Sheet for more details.
Our open meeting will be held via webinar only.
Individuals interested in making a presentation on a proposed LCD must register online.
Registration to be a presenter for the Friday, September 13 meeting is now open and will be closed at noon ET on Wednesday, September 11.
Please note: Presentations submitted will be made public and included as part of the comments in the proposed LCD record. As a Medicare Administrative Contractor (MAC) we are required to follow Federal Section 508 compliance guidelines, which includes documents published on our website. In addition to completing a financial disclosure/Conflict of Interest form, registered presenters will also be required to complete a disclosure form in order for us to publish and use their presentation as comments for a Proposed LCD.
When submitting presentations:
Speaking points and/or a summary of your presentation in a Microsoft Word document is preferred rather than a PowerPoint (PPT) slide presentation.
Word documents and PowerPoint presentations are to be submitted in compliant Section 508 format. Please refer to the
Section 508 website and click on the
Content Creation tab for further information.
PowerPoint presentations that do not meet Section 508 compliance requirements will be altered by the MAC to be Section 508 compliant. Non-compliant PowerPoint presentations will not be published to our website.
Observers are welcome to attend via webinar. Observers must register online.
Registration for observers to attend the Friday, September 13 meeting is now open and will remain open through the meeting.
Please note that the open meeting is not a forum for discussing the following:
Specific claims
Submission of new drugs
Indications
Marketing of forthcoming drugs or medical devices
Information regarding new drugs, indications, or marketing information should be submitted according to Novitas Solutions’ protocol.
Specific claim questions, including billing, pricing, and coding, should be directed to our JL Customer Service Center at 1-877-235-8073.
All open meetings will be recorded. You may listen to the audio recording and/or read the written transcript for prior meetings here.